May 14, 2015 — A new study reports that antiplatelet drug ticagrelor (Brilinta) works faster and is more effective in bl ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
May 14, 2015
May 14, 2015 — Combining statins for low-density lipoprotein (LDL) and calcium channel antagonists for blood pressure re ...
May 14, 2015
May 6, 2015 — People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent ...
May 06, 2015One life-threatening complication of lung cancer surgery is the formation of blood clots in the lungs (also called ...
May 01, 2015
April 30, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental new ...
April 30, 2015
April 29, 2015 — The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and ...
April 29, 2015
April 16, 2015 — The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce ...
April 16, 2015April 9, 2015 — A study including more than 20,000 adults in China found combined use of the hypertension medication ...
April 09, 2015March 30, 2015 — The Medicines Company announced that the European Commission has granted marketing authorization for ...
March 30, 2015
March 30, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved a new ...
March 30, 2015March 25, 2015 — Adding the antiplatelet drug ticagrelor (Brilinta) to aspirin as long-term therapy after a heart attack ...
March 26, 2015March 15, 2015 — A novel therapy that would allow doctors to turn the body’s blood clotting ability off and on in a more ...
March 25, 2015March 24, 2015 — Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug ...
March 24, 2015
March 19, 2015 — Data from a meta-analysis published recently in The Lancet found that extended-duration dual ...
March 19, 2015
March 16, 2015 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Watchman ...
March 16, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now